These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9124619)

  • 1. Double-blind randomized placebo-controlled trial of the use of granulocyte-macrophage colony-stimulating factor in chronic leg ulcers.
    Marques da Costa R; Jesus FM; Aniceto C; Mendes M
    Am J Surg; 1997 Mar; 173(3):165-8. PubMed ID: 9124619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled, dose- ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers.
    Da Costa RM; Ribeiro Jesus FM; Aniceto C; Mendes M
    Wound Repair Regen; 1999; 7(1):17-25. PubMed ID: 10231502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.
    Cianfarani F; Tommasi R; Failla CM; Viviano MT; Annessi G; Papi M; Zambruno G; Odorisio T
    Br J Dermatol; 2006 Jan; 154(1):34-41. PubMed ID: 16403091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers.
    Jaschke E; Zabernigg A; Gattringer C
    Int J Dermatol; 1999 May; 38(5):380-6. PubMed ID: 10369552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Low-dose topical recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) therapy for chronic venous leg ulcers, 10-year follow-up].
    Jaschke E; Umlauft J; Palmer-Reichel K; Oberaigner W; Schmuth M
    Dermatologie (Heidelb); 2023 Jan; 74(1):41-48. PubMed ID: 36287238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healing of chronic leg ulcers in diabetic necrobiosis lipoidica with local granulocyte-macrophage colony stimulating factor treatment.
    Remes K; Rönnemaa T
    J Diabetes Complications; 1999; 13(2):115-8. PubMed ID: 10432176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human GM-CSF in the treatment of poorly healing wounds.
    Groves RW; Schmidt-Lucke JA
    Adv Skin Wound Care; 2000; 13(3 Pt 1):107-12. PubMed ID: 11075003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human granulocyte-macrophage colony-stimulating factor as treatment for chronic leg ulcers.
    Borbolla-Escoboza JR; María-Aceves R; López-Hernández MA; Collados-Larumbe MT
    Rev Invest Clin; 1997; 49(6):449-51. PubMed ID: 9528304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healing of chronic leg ulcers in the hemoglobinopathies with perilesional injections of granulocyte-macrophage colony-stimulating factor.
    Voskaridou E; Kyrtsonis MC; Loutradi-Anagnostou A
    Blood; 1999 May; 93(10):3568-9. PubMed ID: 10366256
    [No Abstract]   [Full Text] [Related]  

  • 10. Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor.
    Bianchi L; Ginebri A; Hagman JH; Francesconi F; Carboni I; Chimenti S
    J Eur Acad Dermatol Venereol; 2002 Nov; 16(6):595-8. PubMed ID: 12482042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Application of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Patients with Wounds.
    Brem H; Howell R; Criscitelli T; Senderowicz A; Siegart N; Gorenstein S; Gillette B
    Surg Technol Int; 2018 Jun; 32():61-66. PubMed ID: 29611156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte/macrophage colony-stimulating factor increases wound-fluid interleukin 8 in normal subjects but does not accelerate wound healing.
    Ure I; Partsch B; Wolff K; Petzelbauer P
    Br J Dermatol; 1998 Feb; 138(2):277-82. PubMed ID: 9602874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte macrophage-colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy.
    Rovirosa A; Ferre J; Biete A
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):747-54. PubMed ID: 9652834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind study of stibogluconate plus human granulocyte macrophage colony-stimulating factor versus stibogluconate alone in the treatment of cutaneous Leishmaniasis.
    Almeida R; D'Oliveira A; Machado P; Bacellar O; Ko AI; de Jesus AR; Mobashery N; Brito Santos J; Carvalho EM
    J Infect Dis; 1999 Nov; 180(5):1735-7. PubMed ID: 10515844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local treatment of a chronic leg ulcer with GM-CSF in a patient with HIV infection.
    Mastroianni A; Cancellieri C
    Sex Transm Infect; 1999 Jun; 75(3):203-4. PubMed ID: 10448409
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial.
    Meisel C; Schefold JC; Pschowski R; Baumann T; Hetzger K; Gregor J; Weber-Carstens S; Hasper D; Keh D; Zuckermann H; Reinke P; Volk HD
    Am J Respir Crit Care Med; 2009 Oct; 180(7):640-8. PubMed ID: 19590022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subcutaneous injection of granulocyte-macrophage colony stimulating factor (GM-CSF) on healing of chronic refractory wounds.
    Malik IA; Zahid M; Haq S; Syed S; Moid I; Waheed I
    Eur J Surg; 1998 Oct; 164(10):737-44. PubMed ID: 9840302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimony plus recombinant human granulocyte-macrophage colony-stimulating factor applied topically in low doses enhances healing of cutaneous Leishmaniasis ulcers: a randomized, double-blind, placebo-controlled study.
    Santos JB; de Jesus AR; Machado PR; Magalhães A; Salgado K; Carvalho EM; Almeida RP
    J Infect Dis; 2004 Nov; 190(10):1793-6. PubMed ID: 15499535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Granulocyte-Macrophage Colony-Stimulating Factor With or Without Supervised Exercise on Walking Performance in Patients With Peripheral Artery Disease: The PROPEL Randomized Clinical Trial.
    McDermott MM; Ferrucci L; Tian L; Guralnik JM; Lloyd-Jones D; Kibbe MR; Polonsky TS; Domanchuk K; Stein JH; Zhao L; Taylor D; Skelly C; Pearce W; Perlman H; McCarthy W; Li L; Gao Y; Sufit R; Bloomfield CL; Criqui MH
    JAMA; 2017 Dec; 318(21):2089-2098. PubMed ID: 29141087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.